Neha Bothra

Expect substantial improvement in performance from Q4: Kamal Sharma, Lupin

India’s third largest pharmaceutical company Lupin reported muted earnings in Q2 FY16 due to a slowdown in approvals that hindered launch of new drugs in US market.

kamal sharma lupin News

PE exits taper off in Q3CY15

Private equity (PE) exits have seen a slight slowdown in Q3CY15 but should gain momentum in Q4CY15, reports Neha Bothra in Mumbai.

PE exits taper off in Q3CY15

Web firms net half PE/VC money

Indian internet companies have raised $5.5 billion in the first nine months of 2015, a jump of over 37% over the $4 billion mopped up in 2014...

Web firms net half PE/VC money

A good year for private equity: Exits, investments at record high

The current calendar year has seen private equity investments to the tune of $11.8 billion, which is higher that $11.1 billion for the whole of calendar 2014.

Private equity News

‘Our fund aims to return around 60% of the capital raised by Q1 of CY16’

Tata Capital Growth Fund (TCGF) raised $220 million in November 2011 and has deployed between $15 million to $30 million in nine portfolio companies.

‘Our fund aims to return around 60% of the capital raised by Q1 of CY16’

Prescription for growth: A booster dose for Cipla

Marking its second biggest acquisition in eight decades, Cipla last week announced the buyout of two US-based drug firms InvaGen Pharma and Exelan Pharma in a cash deal pegged at $550 million.

subhanu saxena cipla News

Prescription for growth: A booster dose for Cipla

Marking its second biggest acquisition in eight decades, Cipla last week announced the buyout of two US-based drug firms InvaGen Pharma and Exelan Pharma in a cash deal pegged at $550 million.

Cipla stake News

Rs 28K crore cash reserves ready to push investment

Money with alternative investment funds up 84% year-on-year

Indian rupee vs us dollar News

VC funding: Nothing ventured, nothing won

PEs led by Sequoia, Tiger Global and Accel are betting big on start-ups riding the digital boom

VC funding: Nothing ventured, nothing won

Prescription for growth: Dr Reddy’s tweaks strategy with eye on US market

The firm will invest in new drugs such as complex generics, biosimilars and proprietary products that offer higher margins besides exploring new markets in Europe

Prescription for growth: Dr Reddy’s tweaks strategy with eye on US market

Private equity firms bank on BFSI, health

After e-commerce firms, private equity investors are betting on banking and financial services companies followed by healthcare and life sciences firms...

fii investment in india News

Will consider inorganic growth opportunities but focus on R&D

Dr Reddy's Laboratories (DRL) is planning to expand footprints in western European countries like France, Italy and Spain

Will consider inorganic growth opportunities but focus on R&D

70% of our new fund will go towards delivery-based entities: Sandeep Aneja

Kaizen Private Equity, the country’s first and largest education-focussed fund established in 2010, is raising a new fund with a corpus of around $150 million.

70% of our new fund will go towards delivery-based entities: Sandeep Aneja

Lupin to strengthen its foothold in US market with Gavis Pharma deal

The Gavis acquisition may look a tad expensive but Lupin expects to strengthen its foothold in the US market and treble sales in three years with its newly bolstered product pipeline

Lupin shares News

SKS Power seeks new investors for Chhattisgarh plant

SKS Power Generation (Chhattisgarh) is in talks to bring in a new investor and raise additional debt to keep its 1,200 MW coal-based power project alive.

Industry News

CDR cell case Visa Steel seeks passport in strategic investor

Visa Steel's plans to expand the capacity of the special steels unit from 0.5 mtpa to 1 mtpa if it is able to access funds from an investor.

Visa Steel News

Heidelberg likely to acquire Lafarge’s eastern India units

German cement major Heidelberg, which is looking to ramp up its capacity in the country through acquisitions, is understood to have placed the highest bid for acquiring the units of Lafarge in eastern India.

lafarge cement News

PE investments on rise in listed firms for better returns

With exits becoming difficult, private equity firms have increasingly begun to invest in listed companies for better returns.

investment News

Angel investors smile big in 2015, pump in $14.67 mn

The current calendar year looks all set to record the highest quantum of angel investments in a single year.

angel investors News

Startups feel the love as angel investors pump in big money

$14.67 m across 56 deals in H1 2015; $16.58 m invested in 2014

strat-ups branding News

With Rs 25K cr cash pool, investment ready to soar

52% more money with AIFs this year; PE deals may be up by 25%

Tax saving options News

Private equities rush for the exit in $4.7-bn push

Private equity (PE) exits in the first half of 2015 at $4.7 billion have outpaced total exits in 2014 worth $3.7 billion, according to Venture Intelligence data.

Sensex, Nifty, bse nse fed rate hike News

Heidelberg to buy Jaiprakash Associates’ cement unit

Jaiprakash Associates' UP cement plant latest in sales series by debt-laden group

binani News

DIAL plans to raise Rs 3,000 crore via bond market

Looks to refinance debt with proceeds

DIAL plans to raise Rs 3,000 crore via bond market

Exchange losses force private equity firms to stay put longer

The sharp depreciation of Indian rupee against the US dollar since 2007 has seen nearly $4 billion being wiped off the investment portfolio of private equity (PE) firms.

indian rupee vs us dollar News

IPO not coming in next five years: RC Juneja

With a valuation of over $1.7 billion, Mankind Pharma is counted among India’s top five drug companies.

IPO not coming in next five years: RC Juneja

Hyperlocal e-commerce catches eye of VC firms

Online firms known for bringing convenience goods and services — grocery, tailoring or fitness services and the likes...

Ecommerce firms Flipkart, Amazon News
FinancialExpress_1x1_Imp_Desktop